![Thomas Dubensky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Dubensky
Chief Executive Officer at
ImmuneSensor Therapeutics, Inc.
Profile
Thomas W.
Dubensky was the founder of Anza Therapeutics, Inc. (2007), holding the title of Chief Scientific Officer in 2010.
Dr. Dubensky is the founder of ImmuneSensor Therapeutics, Inc., serving as President, Chief Executive Officer & Director since 2024.
Former positions include Chief Executive Officer & Director at TempestTx, Inc., Scientific Director at Chiron Corp., Director at HTG Molecular Diagnostics, Inc. (2022-2023), President & Director at Tempest Therapeutics, Inc. (2017-2023), Vice President at Onyx Pharmaceuticals, Inc., Vice President-Research at Cerus Corp.
(2002-2007), Chief Scientific Officer at Aduro BioTech, Inc. (2011-2017), Principal at Chiron Viagene, Inc., and Chief Scientific Officer at Immune Design Corp.
Education includes an undergraduate degree from the University of California, Berkeley and a doctorate from the University of Colorado Health Sciences Center.
Thomas Dubensky active positions
| Companies | Position | Start |
|---|---|---|
ImmuneSensor Therapeutics, Inc.
 ImmuneSensor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Chief Executive Officer | 2024-04-30 |
Former positions of Thomas Dubensky
| Companies | Position | End |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | President | 2023-09-14 |
| HTG MOLECULAR DIAGNOSTICS, INC. | Director/Board Member | 2023-07-31 |
| CHINOOK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2017-08-30 |
| CERUS CORPORATION | Chief Tech/Sci/R&D Officer | 2007-11-15 |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Chief Executive Officer | - |
Training of Thomas Dubensky
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
49
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
HTG Molecular Diagnostics, Inc.
 HTG Molecular Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides molecular technology solutions | Commercial Services |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
Chiron Viagene, Inc.
 Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Commercial biotechnical research | Commercial Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Health Sciences Center
 University of Colorado Health Sciences Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anza Therapeutics, Inc.
 Anza Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic vaccines for cancer and infectious diseases | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
ImmuneSensor Therapeutics, Inc.
ImmuneSensor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Thomas Dubensky
